GGrantIndex
Sort

78,016 grants matching breast cancer

Identifying Cancer Recurrence with Novel Data Linkages with a Cancer Registry

$648,152
Jennifer A. Doherty · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA

microRNAs in Human Cancer

$648,078
Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2009 · CA

HIFU-immunotherapy in pancreatic cancer

$648,066
Katherine W Ferrara · Stanford University · R01 · FY2020 · CA

Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors

$648,024
Julie A Sterling · Vanderbilt University Medical Center · R01 · FY2025 · CA

High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1

$648,006
Douglas Faigel · Mayo Clinic Arizona · R01 · FY2018 · CA

UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10

$648,000
Joan H Schiller · Ut Southwestern Medical Center · U10 · FY2014 · CA

Planning and Evaluation Core

$647,912
Jason A Wilder · Northern Arizona University · U54 · FY2023 · CA

Cbl Proteins as Regulators of Tyrosine Kinase Signaling

$647,907
Stanley Lipkowitz · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials

$647,891
Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2022 · CA

Insulin and IGF In female colon, breast, uterine cancer

$647,877
Yeshiva University · R01 · FY2002 · CA

Integrative Molecular Profiling of Human Pancreatic Cancer

$647,802
Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Developing Informatics Technologies to Model Cancer Gene Regulation

$647,787
Clifford Meyer · Dana-Farber Cancer Inst · U24 · FY2022 · CA

Synthetic mRNA-mediated reversible immunocontraception

$647,780
Philip J Santangelo · Emory University · R33 · FY2022 · HD

Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol

$647,779
Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2014 · DK

Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers

$647,703
Jacek Capala · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

FINDING THE M.I.N.C. FOR MAMMOGRAPHY MAINTENANCE

$647,673
University Of North Carolina Chapel Hill · R01 · FY2005 · CA

High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells

$647,628
Mehmet Toner · Massachusetts General Hospital · R01 · FY2025 · CA

Functional Analysis of Breast Cancer Susceptibility Genes in Mice

$647,584
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Functional Analysis of Human Breast Cancer Susceptibility Gene Variants

$647,584
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

DEFINING AND THERAPEUTICALLY TARGETING THE IMMUNOLOGICAL LANDSCAPE OF SF3B1-MUTANT BREAST CANCER

$647,550
Fred Hutchinson Cancer Center · · FY2020 · Defense Health Agency

Functional Analysis of Human Breast Cancer Susceptibility Gene Variants

$647,522
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Prevention of Osteoporosis in Breast Cancer Survivors

$647,492
University Of Nebraska Medical Center · R01 · FY2002 · NR

Accelerated biological aging in breast cancer and risk for cognitive and physical complaints

$647,400
Judith E Carroll · University Of California Los Angeles · R01 · FY2020 · CA

Epigenetics and Psychoneurologic Symptoms in Women with Breast Cancer

$647,373
Debra E Lyon · Virginia Commonwealth University · R01 · FY2011 · NR

CTL-killing capacity and cancer stiffness in cancer immunity and therapy

$647,366
Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2022 · CA